These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15333651)

  • 1. Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer.
    Brunner A; Mayerl C; Tzankov A; Verdorfer I; Tschörner I; Rogatsch H; Mikuz G
    J Clin Pathol; 2004 Sep; 57(9):927-31. PubMed ID: 15333651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
    Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
    Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    Quintero A; Alvarez-Kindelan J; Luque RJ; Gonzalez-Campora R; Requena MJ; Montironi R; Lopez-Beltran A
    J Clin Pathol; 2006 Jan; 59(1):83-8. PubMed ID: 16394286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
    Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
    BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin-C in primary malignant melanoma of the skin.
    Ilmonen S; Jahkola T; Turunen JP; Muhonen T; Asko-Seljavaara S
    Histopathology; 2004 Oct; 45(4):405-11. PubMed ID: 15469480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenascin-C in primary Merkel cell carcinoma.
    Koljonen V; Jahkola T; Tukiainen E; Granroth G; Haglund C; Böhling T
    J Clin Pathol; 2005 Mar; 58(3):297-300. PubMed ID: 15735164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder.
    Booth C; Harnden P; Selby PJ; Southgate J
    J Pathol; 2002 Nov; 198(3):359-68. PubMed ID: 12375269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Salmas M; Malamou-Mitsi V
    BJU Int; 2005 Mar; 95(4):655-9. PubMed ID: 15705098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.
    Atula T; Hedström J; Finne P; Leivo I; Markkanen-Leppänen M; Haglund C
    Anticancer Res; 2003; 23(3C):3051-6. PubMed ID: 12926160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
    J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
    Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C
    Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34.
    Ajili F; Kacem M; Tounsi H; Darouiche A; Enayfer E; Chebi M; Manai M; Boubaker S
    Ultrastruct Pathol; 2012 Oct; 36(5):336-42. PubMed ID: 22574784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer.
    Li M; Song T; Yin ZF; Na YQ
    Chin Med J (Engl); 2007 Mar; 120(6):469-73. PubMed ID: 17439739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
    Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
    Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma.
    Sis B; Sağol O; Küpelioğlu A; Sokmen S; Terzi C; Fuzun M; Ozer E; Bishop P
    Pathol Res Pract; 2004; 200(5):379-87. PubMed ID: 15239346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder.
    Berndt A; Anger K; Richter P; Borsi L; Brack S; Silacci M; Franz M; Wunderlich H; Gajda M; Zardi L; Neri D; Kosmehl H
    J Cancer Res Clin Oncol; 2006 Aug; 132(8):537-46. PubMed ID: 16788848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.